Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors

Xiaobo Cao, James E Littlejohn, Charles Rodarte, Lidong Zhang, Benjamin Martino, Philip Rascoe, Kamran Hamid, Daniel Jupiter, W. Roy Smythe

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Bcl-xl and the hepatocyte growth factor (HGF) receptor c-Met are both highly expressed in mesotheliomas, where they protect cells from apoptosis and can confer resistance to conventional therapeutic agents. In our current study, we investigate a model for the transcriptional control of Bcl-xl that involves ETS transcription factors and the HGF/Met axis. In addition, the effects of activated c-Met on the phosphorylation of the ETS family transcriptional factors were examined. The transient expression of ETS-2 and PU.1 cDNAs in mesothelioma cell lines resulted in an increase in the promoter activity of Bcl-xl and consequently in its mRNA and protein expression levels, whereas the transcriptional repressor Tel suppressed Bcl-xl transcription. The activation of the HGF/Met axis led to rapid phosphorylation of ETS family transcription factors in mesothelioma cells through the mitogen-activated protein kinase pathway and via nuclear accumulation of ETS-2 and PU.1. A chromatin immunoprecipitation assay further demonstrated that the activation of c-Met enhanced the binding of ETS transcriptional factors to the Bcl-x promoter. Finally, we determined the Bcl-xl and phosphorylated c-Met expression levels in mesothelioma patient samples; these data suggest a strong correlation between Bcl-xl and phosphorylated c-Met levels. Taken together, these findings support a role for c-Met as an inhibitor of apoptosis and an activator of Bcl-xl.

Original languageEnglish (US)
Pages (from-to)2207-2216
Number of pages10
JournalAmerican Journal of Pathology
Volume175
Issue number5
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Mesothelioma
Transcription Factors
Up-Regulation
Hepatocyte Growth Factor
Phosphorylation
Proto-Oncogene Proteins c-met
Apoptosis
Chromatin Immunoprecipitation
Mitogen-Activated Protein Kinases
Complementary DNA
Cell Line
Messenger RNA
human HGF protein
Proteins
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors. / Cao, Xiaobo; Littlejohn, James E; Rodarte, Charles; Zhang, Lidong; Martino, Benjamin; Rascoe, Philip; Hamid, Kamran; Jupiter, Daniel; Smythe, W. Roy.

In: American Journal of Pathology, Vol. 175, No. 5, 2009, p. 2207-2216.

Research output: Contribution to journalArticle

Cao, Xiaobo ; Littlejohn, James E ; Rodarte, Charles ; Zhang, Lidong ; Martino, Benjamin ; Rascoe, Philip ; Hamid, Kamran ; Jupiter, Daniel ; Smythe, W. Roy. / Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors. In: American Journal of Pathology. 2009 ; Vol. 175, No. 5. pp. 2207-2216.
@article{8be688a28dd44a6c89720779557e50ac,
title = "Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors",
abstract = "Bcl-xl and the hepatocyte growth factor (HGF) receptor c-Met are both highly expressed in mesotheliomas, where they protect cells from apoptosis and can confer resistance to conventional therapeutic agents. In our current study, we investigate a model for the transcriptional control of Bcl-xl that involves ETS transcription factors and the HGF/Met axis. In addition, the effects of activated c-Met on the phosphorylation of the ETS family transcriptional factors were examined. The transient expression of ETS-2 and PU.1 cDNAs in mesothelioma cell lines resulted in an increase in the promoter activity of Bcl-xl and consequently in its mRNA and protein expression levels, whereas the transcriptional repressor Tel suppressed Bcl-xl transcription. The activation of the HGF/Met axis led to rapid phosphorylation of ETS family transcription factors in mesothelioma cells through the mitogen-activated protein kinase pathway and via nuclear accumulation of ETS-2 and PU.1. A chromatin immunoprecipitation assay further demonstrated that the activation of c-Met enhanced the binding of ETS transcriptional factors to the Bcl-x promoter. Finally, we determined the Bcl-xl and phosphorylated c-Met expression levels in mesothelioma patient samples; these data suggest a strong correlation between Bcl-xl and phosphorylated c-Met levels. Taken together, these findings support a role for c-Met as an inhibitor of apoptosis and an activator of Bcl-xl.",
author = "Xiaobo Cao and Littlejohn, {James E} and Charles Rodarte and Lidong Zhang and Benjamin Martino and Philip Rascoe and Kamran Hamid and Daniel Jupiter and Smythe, {W. Roy}",
year = "2009",
doi = "10.2353/ajpath.2009.090070",
language = "English (US)",
volume = "175",
pages = "2207--2216",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors

AU - Cao, Xiaobo

AU - Littlejohn, James E

AU - Rodarte, Charles

AU - Zhang, Lidong

AU - Martino, Benjamin

AU - Rascoe, Philip

AU - Hamid, Kamran

AU - Jupiter, Daniel

AU - Smythe, W. Roy

PY - 2009

Y1 - 2009

N2 - Bcl-xl and the hepatocyte growth factor (HGF) receptor c-Met are both highly expressed in mesotheliomas, where they protect cells from apoptosis and can confer resistance to conventional therapeutic agents. In our current study, we investigate a model for the transcriptional control of Bcl-xl that involves ETS transcription factors and the HGF/Met axis. In addition, the effects of activated c-Met on the phosphorylation of the ETS family transcriptional factors were examined. The transient expression of ETS-2 and PU.1 cDNAs in mesothelioma cell lines resulted in an increase in the promoter activity of Bcl-xl and consequently in its mRNA and protein expression levels, whereas the transcriptional repressor Tel suppressed Bcl-xl transcription. The activation of the HGF/Met axis led to rapid phosphorylation of ETS family transcription factors in mesothelioma cells through the mitogen-activated protein kinase pathway and via nuclear accumulation of ETS-2 and PU.1. A chromatin immunoprecipitation assay further demonstrated that the activation of c-Met enhanced the binding of ETS transcriptional factors to the Bcl-x promoter. Finally, we determined the Bcl-xl and phosphorylated c-Met expression levels in mesothelioma patient samples; these data suggest a strong correlation between Bcl-xl and phosphorylated c-Met levels. Taken together, these findings support a role for c-Met as an inhibitor of apoptosis and an activator of Bcl-xl.

AB - Bcl-xl and the hepatocyte growth factor (HGF) receptor c-Met are both highly expressed in mesotheliomas, where they protect cells from apoptosis and can confer resistance to conventional therapeutic agents. In our current study, we investigate a model for the transcriptional control of Bcl-xl that involves ETS transcription factors and the HGF/Met axis. In addition, the effects of activated c-Met on the phosphorylation of the ETS family transcriptional factors were examined. The transient expression of ETS-2 and PU.1 cDNAs in mesothelioma cell lines resulted in an increase in the promoter activity of Bcl-xl and consequently in its mRNA and protein expression levels, whereas the transcriptional repressor Tel suppressed Bcl-xl transcription. The activation of the HGF/Met axis led to rapid phosphorylation of ETS family transcription factors in mesothelioma cells through the mitogen-activated protein kinase pathway and via nuclear accumulation of ETS-2 and PU.1. A chromatin immunoprecipitation assay further demonstrated that the activation of c-Met enhanced the binding of ETS transcriptional factors to the Bcl-x promoter. Finally, we determined the Bcl-xl and phosphorylated c-Met expression levels in mesothelioma patient samples; these data suggest a strong correlation between Bcl-xl and phosphorylated c-Met levels. Taken together, these findings support a role for c-Met as an inhibitor of apoptosis and an activator of Bcl-xl.

UR - http://www.scopus.com/inward/record.url?scp=73649086545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649086545&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2009.090070

DO - 10.2353/ajpath.2009.090070

M3 - Article

C2 - 19834061

AN - SCOPUS:73649086545

VL - 175

SP - 2207

EP - 2216

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -